Getinge (OTCMKTS:GNGBY) Shares Gap Up – Should You Buy?

Getinge (OTCMKTS:GNGBY) shares gapped up before the market opened on Friday . The stock had previously closed at $21.53, but opened at $24.18. Getinge shares last traded at $24.18, with a volume of 107 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Getinge to a “hold” rating in a research note on Thursday, April 23rd. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Getinge presently has a consensus rating of “Moderate Buy”.

Getinge Stock Up 11.4%

The business has a fifty day moving average of $20.57 and a 200 day moving average of $21.32. The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27. The firm has a market cap of $6.59 billion, a P/E ratio of 26.28 and a beta of 0.96.

Getinge (OTCMKTS:GNGBY) last issued its earnings results on Friday, July 17th. The company reported $0.38 earnings per share (EPS) for the quarter. Getinge had a return on equity of 10.39% and a net margin of 6.92%. On average, equities research analysts predict that Getinge will post 1.26 EPS for the current year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.